Correspondence 0001437749-23-016901 from Genprex, Inc. (GNPX)
Genprex, Inc.
Date: June 7, 2023 · CIK: 0001595248 · Accession: 0001437749-23-016901
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271386
Letter
gnpx20230521_corresp.htm
3300 Bee Cave Road, #650-227
Austin, TX 78746
June 7, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jason Drory
Re:
Genprex, Inc.
Registration Statement on Form S-3
Filed on April 21, 2023
File No. 333-271386
Acceleration Request
Requested Date: June 9, 2023
Requested Time: 4:30 p.m., Eastern Time
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement (the "Registration Statement"), and pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Genprex, Inc. (the "Company") hereby requests that the above-mentioned Registration Statement be declared effective by the Securities and Exchange Commission (the "Commission") at 4:30 p.m., Eastern Time, on June 9, 2023, or as soon thereafter as practicable.
Please call Alan Wovsaniker of Lowenstein Sandler LLP at 973-597-2564 to confirm the effectiveness of the Registration Statement or with any questions that you may have.
GENPREX, INC.
By:
/s/ Ryan M. Confer
Name:
Ryan M. Confer
Title:
Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm gnpx20230521_corresp.htm 3300 Bee Cave Road, #650-227 Austin, TX 78746 June 7, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Genprex, Inc. Registration Statement on Form S-3 Filed on April 21, 2023 File No. 333-271386 Acceleration Request Requested Date: June 9, 2023 Requested Time: 4:30 p.m., Eastern Time Ladies and Gentlemen: In connection with the above-captioned Registration Statement (the "Registration Statement"), and pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Genprex, Inc. (the "Company") hereby requests that the above-mentioned Registration Statement be declared effective by the Securities and Exchange Commission (the "Commission") at 4:30 p.m., Eastern Time, on June 9, 2023, or as soon thereafter as practicable. Please call Alan Wovsaniker of Lowenstein Sandler LLP at 973-597-2564 to confirm the effectiveness of the Registration Statement or with any questions that you may have. GENPREX, INC. By: /s/ Ryan M. Confer Name: Ryan M. Confer Title: Chief Financial Officer